A detailed history of Intelligence Driven Advisers, LLC transactions in Amgen Inc stock. As of the latest transaction made, Intelligence Driven Advisers, LLC holds 964 shares of AMGN stock, worth $273,400. This represents 0.04% of its overall portfolio holdings.

Number of Shares
964
Previous 649 48.54%
Holding current value
$273,400
Previous $202,000 53.47%
% of portfolio
0.04%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$309.38 - $337.38 $97,454 - $106,274
315 Added 48.54%
964 $310,000
Q2 2024

Aug 05, 2024

SELL
$262.75 - $319.31 $145,300 - $176,578
-553 Reduced 46.01%
649 $202,000
Q1 2024

May 01, 2024

SELL
$268.87 - $324.56 $120,184 - $145,078
-447 Reduced 27.11%
1,202 $341,000
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $40,400 - $45,576
158 Added 10.6%
1,649 $474,000
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $91,614 - $113,741
419 Added 39.09%
1,491 $400,000
Q2 2023

Jul 18, 2023

SELL
$214.27 - $253.37 $69,637 - $82,345
-325 Reduced 23.26%
1,072 $238,000
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $27,546 - $33,574
122 Added 9.57%
1,397 $337,000
Q4 2022

Jan 23, 2023

BUY
$229.03 - $291.01 $73,060 - $92,832
319 Added 33.37%
1,275 $351,000
Q3 2022

Oct 21, 2022

BUY
$224.46 - $253.15 $13,916 - $15,695
62 Added 6.94%
956 $221,000
Q2 2022

Jul 22, 2022

SELL
$230.71 - $256.74 $343,757 - $382,542
-1,490 Reduced 62.5%
894 $219,000
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $221,751 - $253,774
1,115 Added 87.86%
2,384 $554,000
Q3 2021

Oct 14, 2021

BUY
$212.27 - $248.7 $269,370 - $315,600
1,269 New
1,269 $269,000
Q3 2020

Oct 09, 2020

SELL
$234.65 - $260.95 $216,816 - $241,117
-924 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $182,776 - $224,291
924 New
924 $218,000
Q1 2020

Sep 04, 2020

SELL
$182.24 - $241.7 $180,782 - $239,766
-992 Closed
0 $0
Q4 2019

Sep 04, 2020

BUY
$189.21 - $243.2 $187,696 - $241,254
992 New
992 $239,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $152B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Intelligence Driven Advisers, LLC Portfolio

Follow Intelligence Driven Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intelligence Driven Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intelligence Driven Advisers, LLC with notifications on news.